Dr. Christos Chouaid
Claim this profileGSK Investigational Site
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
8 reported clinical trials
15 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
MET positive
2Lung Cancer
Stage IV
Stage III
Clinical Trials Christos Chouaid is currently running
Sigvotatug Vedotin vs Docetaxel
for Lung Cancer
This trial is testing a new drug, sigvotatug vedotin, against a standard drug, docetaxel, in patients with advanced lung cancer. The goal is to see if the new drug works better and to understand its side effects. Docetaxel (Taxotere) is a well-established chemotherapy agent used in the treatment of advanced non-small cell lung cancer (NSCLC), often after failure of first-line treatments.
Recruiting2 awards Phase 35 criteria
M1774 + Cemiplimab
for Advanced Lung Cancer
This is an Open-label, multicenter clinical study conducted in two Phases to establish the efficacy, safety, tolerability, and pharmacokinetics of the ataxia telangiectasia mutated and Rad3-related protein kinase (ATR) inhibitor Tuvusertib in Combination with Cemiplimab in Participants with Non-Squamous Non-Small Cell Lung Cancer (nsqNSCLC) that has Progressed on Prior Anti-PD-(L)1 and Platinum-based Therapies..
Recruiting1 award Phase 1 & 28 criteria
More about Christos Chouaid
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Christos Chouaid has experience with
- Docetaxel
- Pyrotinib
- Niraparib
- Pembrolizumab
- Placebo
- Alectinib
Breakdown of trials Christos Chouaid has run
Non-Small Cell Lung Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christos Chouaid specialize in?
Christos Chouaid focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Christos Chouaid currently recruiting for clinical trials?
Yes, Christos Chouaid is currently recruiting for 3 clinical trials in Creteil Ile-de-france. If you're interested in participating, you should apply.
Are there any treatments that Christos Chouaid has studied deeply?
Yes, Christos Chouaid has studied treatments such as Docetaxel, Pyrotinib, Niraparib.
What is the best way to schedule an appointment with Christos Chouaid?
Apply for one of the trials that Christos Chouaid is conducting.
What is the office address of Christos Chouaid?
The office of Christos Chouaid is located at: Centre Hospitalier Intercommunal de Creteil, Creteil, Ile-de-france 94010 France. This is the address for their practice at the Centre Hospitalier Intercommunal de Creteil.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.